Literature DB >> 8887576

Spontaneous and induced sputum to measure indices of airway inflammation in asthma.

M M Pizzichini1, T A Popov, A Efthimiadis, P Hussack, S Evans, E Pizzichini, J Dolovich, F E Hargreave.   

Abstract

Inhalation of hypertonic saline to induce sputum may alter cells and fluid-phase markers in sputum. We have compared indices of inflammation in sputum produced spontaneously with sputum induced by an aerosol of hypertonic saline. Twenty-three asthmatics produced spontaneous followed by induced sputum on the same day. The sputum specimen was separated from saliva within 2 h, dispersed with dithiothreitol (DTT) and processed to obtain cytospins and supernatant. The statistical power to detect a 20% difference in sputum parameters was > 90%. Results are expressed as median and interquartile range [IQR]. Induced sputum had a higher proportion of viable cells (77.0 [19.0] versus 47.0 [38.0]%, p < 0.001), less squamous cell contamination (1.0 [1.2] versus 1.8 [34.0]%, p < 0.001) and better quality cytospins (score of 8.0 [4.0] versus 4.0 [2.0], p < 0.001). It also had lower fluid-phase levels of eosinophil cationic protein (ECP) (1,358 [1,102] versus 1,574 [2,479] microg/L) and fibrinogen (1,560.0 [3,130.0] versus 4,350.0 [5,970.0] ng/ml) but only the latter was significantly different (p = 0.02). Induced sputum was similar to spontaneous sputum in weight (200.0 [219.0] versus 270.0 [227.0] mg), total cell count (3.3 [4.1] versus 3.5 [4.5] x 10(6)/ml), proportion of nonsquamous cells, and levels of tryptase. The agreement between induced and spontaneous measurements was good, but fluid-phase levels were affected by the low viability of some spontaneous samples. We conclude that for the indices measured in asthmatic subjects, induced sputum separated from saliva is similar to lower respiratory secretions expectorated spontaneously and has the advantage of better cell viability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887576     DOI: 10.1164/ajrccm.154.4.8887576

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

Review 1.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

2.  The efficiency of sputum cell counts in cystic fibrosis.

Authors:  L Jayaram; N R Labiris; A Efthimiadis; H Valchos-Mayer; F E Hargreave; A P Freitag
Journal:  Can Respir J       Date:  2007-03       Impact factor: 2.409

3.  A kit to facilitate and standardize the processing of sputum for measurement of airway inflammation.

Authors:  Simone Chaboillez; Angira Dasgupta; Philippe Prince; Louis-Philippe Boulet; Catherine Lemière
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

Review 4.  Management of asthma in adults.

Authors:  Meyer S Balter; Alan D Bell; Alan G Kaplan; Harold Kim; R Andrew McIvor
Journal:  CMAJ       Date:  2009-09-28       Impact factor: 8.262

5.  Changes in sputum composition between two inductions performed on consecutive days.

Authors:  O Holz; K Richter; R A Jörres; P Speckin; M Mücke; H Magnussen
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

6.  Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.

Authors:  Liesel D'silva; Nesreen Hassan; Hong-Yu Wang; Melanie Kjarsgaard; Ann Efthimiadis; Frederick E Hargreave; Parameswaran Nair
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

7.  Effect of repeated sputum induction on cell counts in normal volunteers.

Authors:  J A Nightingale; D F Rogers; P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

Review 8.  Update on clinical inflammometry for the management of airway diseases.

Authors:  Parameswaran Nair
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

9.  Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis.

Authors:  I S Woolhouse; D L Bayley; R A Stockley
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

10.  Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.

Authors:  S L Traves; S V Culpitt; R E K Russell; P J Barnes; L E Donnelly
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.